SS

Suyash Sharma

Active Director Director DIN 07091784
DIN 07091784 First appointment Aug 2023 Primary industry Paper
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2023
Shareholding value •••• Premium profile

About Suyash Sharma

Data last updated:

Suyash Sharma is a Director at Shastri Pharma Private Limited (since 2023). The company operates in Paper. Shastri Pharma Private Limited reported revenue of ₹2.2 Lakh (FY 2025).

DIN 07091784
Primary Designation Director
Industry Paper
First Appointment 05 Aug 2023
Oldest Company Age 3 yrs
Largest company Shastri Pharma Private Limited · ₹2.2 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Shastri Pharma Private Limited U21001GJ2023PTC141662
Director05 Aug 20232023₹2.2 Lakh (FY 2025)Active

Board colleagues of Suyash Sharma

Directorship timeline

Open interactive timeline →
Shastri Pharma Private Limited
Premium access

Shareholding and investment profile for Suyash Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suyash Sharma

Suyash Sharma currently holds 1 directorship: Shastri Pharma Private Limited (Director, since 05 Aug 2023, revenue ₹2.2 Lakh (FY 2025)).

Suyash Sharma was first appointed on 05 Aug 2023 as Director at Shastri Pharma Private Limited.

The current boards of Suyash Sharma's companies include Prakash Sharma (Shastri Pharma Private Limited), Priti Tripathi (Shastri Pharma Private Limited), Sparsh Sharma (Shastri Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available